Aprinoia Therapeutics
PrivateLast Round
Grant
Sep 11, 2023
Total Funding Raised
$55.5M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Aprinoia Therapeutics is a biotechnology company that develops diagnostic tools and therapeutics for a broad range of neurodegenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical Imaging, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aprinoia Therapeutics Comparables
Compare Aprinoia Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Lantheus Holdings Inc. | 80% | |
| AC Immune SA | 79% | |
| Roche Holding | 78% | |
Aprinoia Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 11, 2023 | ||||
| Series C | Dec 28, 2021 | ||||
| Series B | Jan 16, 2018 | ||||
| Seed | May 1, 2015 |
Aprinoia Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| TaiAn Technologies Corp. | Series B, Series C |
| IMM Investment | Series C |
| DCI Partners | Series A, Series B |
| Harvest Capital (Suzhou Industrial Park) | Series C |
| ShangPharma Innovation | Series B |
| Daol Investment | Series A, Series C, Series B |
| National Development Fund | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 367% MoM.
- Jan 26, 2026
Monthly visitors grew 648% MoM, from 668 to 5K.
Aprinoia Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Aprinoia Therapeutics's valuation, stock price, and market status.